MAVACAMTEN: A door that has opened in the treatment of Hyper-trophic Cardiomyopathy Authors Ishaque Hameed Department of Internal Medicine, Dow University of Health and Sciences, Civil Hospital, Karachi, Pakistan Omer Mustafa Siddiqui Department of Internal Medicine, Dow University of Health and Sciences, Civil Hospital, Karachi, Pakistan Syed Abdus Samad Department of General Surgery, Dow University of Health and Sciences, Civil Hospital, Karachi, Pakistan DOI: https://doi.org/10.47391/JPMA.7258 Abstract Not Applicable. Downloads Full Text Article Published 2023-02-15 How to Cite Hameed , I., Siddiqui, O. M., & Samad, S. A. (2023). MAVACAMTEN: A door that has opened in the treatment of Hyper-trophic Cardiomyopathy. Journal of the Pakistan Medical Association, 73(2), 446–447. https://doi.org/10.47391/JPMA.7258 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 73 No. 2 (2023): February Section LETTER TO THE EDITOR